OGN is currently developing the following drugs: Vehicle Cream, Tapinarof Cream, 1%, Vtama (Tapinarof) Cream, 1%, Vtama (Tapinarof) Cream 1%, Vtama, Tapinarof Cream 1%, Vtama (Tapinarof) Cream, 1%. These drug candidates are in various stages of clinical development as the company works toward FDA approval.